DrugPatentWatch Database Preview

Details for Patent: 6,465,504

« Back to Dashboard

Which drugs does patent 6,465,504 protect, and when does it expire?

Patent 6,465,504 protects JADENU SPRINKLE, EXJADE, and JADENU, and is included in three NDAs.

This patent has forty-six patent family members in thirty-four countries.

Summary for Patent: 6,465,504

Title:	Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
Abstract:	The use is described of 3,5-diphenyl-1,2,4-triazoles of the formula I ##STR1## in which R.sub.1 -R.sub.5 are as defined in the description. The compounds have useful pharmaceutical properties and are particularly active as iron chelators. They can be used for the treatment of iron overload in warm-blooded animals.
Inventor(s):	Lattmann; Rene (Binningen, SE), Acklin; Pierre (Basel, SE)
Assignee:	Novartis AG (Basel, CH)
Application Number:	09/699,765
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 6,465,504
Patent Claim Types: see list of patent claims	Compound; Composition;

Drugs Protected by US Patent 6,465,504

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Patent Submitted
Novartis Pharms Corp	JADENU SPRINKLE	deferasirox	GRANULE;ORAL	207968-001	May 18, 2017		RX	Yes	No			Y	Y
Novartis Pharms Corp	JADENU SPRINKLE	deferasirox	GRANULE;ORAL	207968-002	May 18, 2017		RX	Yes	No			Y	Y
Novartis Pharms Corp	JADENU SPRINKLE	deferasirox	GRANULE;ORAL	207968-003	May 18, 2017		RX	Yes	Yes			Y	Y
Novartis	EXJADE	deferasirox	TABLET, FOR SUSPENSION;ORAL	021882-001	Nov 2, 2005	AB	RX	Yes	No			Y	Y

Foreign Priority and PCT Information for Patent: 6,465,504

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	1593/96	Jun 25, 1996

Non-Orange Book US Patents Family Members for Patent 6,465,504

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No.	Title	Estimated Patent Expiration
6,596,750	Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
6,723,742	Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators

International Family Members for US Patent 6,465,504

Country	Document Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
African Regional IP Organization (ARIPO)	1127
African Regional IP Organization (ARIPO)	9801407
Argentina	007479
Austria	226435